title: Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids.
authors.forename: Nisha
authors.initials: N
authors.lastname: Vasavda
authors.forename: Claire
authors.initials: C
authors.lastname: Woodley
authors.forename: Marlene
authors.initials: M
authors.lastname: Allman
authors.forename: Emma
authors.initials: E
authors.lastname: Drašar
authors.forename: Moji
authors.initials: M
authors.lastname: Awogbade
authors.forename: Jo
authors.initials: J
authors.lastname: Howard
authors.forename: Swee L
authors.initials: SL
authors.lastname: Thein
mesh_terms: D000755:Anemia, Sickle Cell / Q000097:blood / Q000150:complications / Q000188:drug therapy; D000986:Antisickling Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage*; D007223:Infant; D008297:Male; D009696:Nucleic Acids / Q000097:blood*; D017085:alpha-Thalassemia / Q000097:blood / Q000150:complications / Q000188:drug therapy
chemical_list: D000986:Antisickling Agents; D009696:Nucleic Acids; D006918:Hydroxyurea